U. Herzberg et al., THE ANALGESIC EFFECTS OF R(-WIN-55,212-2 MESYLATE, A HIGH-AFFINITY CANNABINOID AGONIST, IN A RAT MODEL OF NEUROPATHIC PAIN()), Neuroscience letters, 221(2-3), 1997, pp. 157-160
The effects of a high affinity cannabinoid receptor agonist were evalu
ated in rats subjected to chronic constriction injury of the sciatic n
erve (CCI) or a sham operation. Intraperitoneal (i.p.) injections of t
he active, but not the inactive enantiomer, alleviated the pain behavi
or exhibited by CCI animals in a dose dependent manner. Moreover, at d
oses ranging from 0.43 to 4.3 mg/kg effects on sensitivity to a heat s
timulus were observed neither in the paw contralateral to the sciatic
ligation, nor in animals subjected to sham surgery. Animals subjected
to CCI and treated with 4.3 mg/kg exhibited hypoalgesia in the paw ips
ilateral to the ligated sciatic, i.e. heat hypoalgesia was completely
reversed. The hypoalgesia is presumed to be the results of unmasking o
f a sensory deficit reflecting the known loss of C and A delta with CC
I. Although side effects were present in some CCI animals subjected to
the high dose (4.3 mg/kg), a moderate dose (2.14 mg/kg) completely al
leviated the thermal and mechanical hyperalgesia, and mechanical allod
ynia without side effects, In addition to identifying a potential drug
treatment for painful neuropathy, this study suggests that changes in
cannabinoid receptors occurs in nerve injured animals. (C) 1997 Elsev
ier Science Ireland Ltd.